{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:50:45Z","timestamp":1791489045603,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"DOI":"10.1038\/s41371-026-01190-1","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T16:55:30Z","timestamp":1785603330000},"page":"787-797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cEfficacy and safety of low-dose combination (Quad pill and Triple pill) therapy versus standard of care and placebo in controlling hypertension: an updated systematic review and meta-analysis of randomized trials\u201d"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8591-0133","authenticated-orcid":false,"given":"Anfal","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinza","family":"Irshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Numan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awais","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"key":"1190_CR1","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S0140-6736(21)01922-X","volume":"398","author":"C Chow","year":"2021","unstructured":"Chow C, Atkins E, Hillis G, et al. Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial. Lancet. 2021;398:1043\u201352.","journal-title":"Lancet"},{"key":"1190_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ahj.2020.09.017","volume":"231","author":"CK Chow","year":"2021","unstructured":"Chow CK, Atkins ER, Billot L, Chalmers J, Hillis GS, Hay P, et al. Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol. Am Heart J. 2021;231:56\u201367. https:\/\/doi.org\/10.1016\/j.ahj.2020.09.017","journal-title":"Am Heart J"},{"key":"1190_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223\u201337. https:\/\/doi.org\/10.1038\/s41581-019-0244-2","journal-title":"Nat Rev Nephrol"},{"key":"1190_CR4","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S0140-6736(17)30260-X","volume":"389","author":"CK Chow","year":"2017","unstructured":"Chow CK, Thakkar J, Bennett A, Hillis G, Burke M, Usherwood T, et al. Rodgers A. Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review. Lancet. 2017;389:1035\u201342. https:\/\/doi.org\/10.1016\/S0140-6736(17)30260-X","journal-title":"Lancet"},{"key":"1190_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jamacardio.2023.0720","volume":"8","author":"N Wang","year":"2023","unstructured":"Wang N, Rueter P, Atkins E, Webster R, Huffman M, de Silva A, et al. Efficacy and safety of low-dose triple and quadruple combination pills vs monotherapy, usual care, or placebo for the initial management of hypertension: a systematic review and meta-analysis. JAMA Cardiol. 2023;8:606\u201311. https:\/\/doi.org\/10.1001\/jamacardio.2023.0720","journal-title":"JAMA Cardiol"},{"key":"1190_CR6","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.5114\/aoms.2018.77561","volume":"14","author":"P Kawalec","year":"2018","unstructured":"Kawalec P, Holko P, Gawin M, Pilc A. Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysis. Arch Med Sci. 2018;14:1125\u201336. https:\/\/doi.org\/10.5114\/aoms.2018.77561","journal-title":"Arch Med Sci"},{"key":"1190_CR7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s40261-023-01313-3","volume":"43","author":"M Abuelazm","year":"2023","unstructured":"Abuelazm M, Ali S, Saleh O, Badr A, Altobaishat O, AlBarakat MM, et al. The safety and efficacy of quadruple ultra-low-dose combination (Quadpill) for hypertension treatment: a systematic review and meta-analysis of randomized controlled trials. Clin Drug Investig. 2023;43:813\u201326. https:\/\/doi.org\/10.1007\/s40261-023-01313-3","journal-title":"Clin Drug Investig"},{"key":"1190_CR8","volume-title":"Global report on hypertension: the race against a silent killer","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Global report on hypertension: the race against a silent killer. Geneva: World Health Organization; 2023."},{"key":"1190_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/jch.14656","volume":"25","author":"KC Sung","year":"2023","unstructured":"Sung KC, Hong SJ, Rhee MY, et al. Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertension. J Clin Hypertens. 2023;25:429\u201339.","journal-title":"J Clin Hypertens"},{"key":"1190_CR10","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(19)31949-X","volume":"394","author":"JD Schwalm","year":"2019","unstructured":"Schwalm JD, McCready T, Lopez-Jaramillo P, et al. A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial. Lancet. 2019;394:1231\u201342.","journal-title":"Lancet"},{"key":"1190_CR11","doi-asserted-by":"publisher","first-page":"7721","DOI":"10.1007\/s00210-025-03790-z","volume":"398","author":"MS Elgendy","year":"2025","unstructured":"Elgendy MS, Taha HI, Amin AM, Khlidj Y, Ezz MR, Elgamasy MA, et al. The efficacy and safety of low-dose triple combination for hypertension treatment: a systematic review and meta-analysis of randomized controlled trials. Naunyn Schmiedebergs Arch Pharmacol. 2025;398:7721\u201336. https:\/\/doi.org\/10.1007\/s00210-025-03790-z","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1190_CR12","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1097\/HJH.0000000000002089","volume":"37","author":"A Salam","year":"2019","unstructured":"Salam A, Atkins ER, Hsu B, Webster R, Patel A, Rodgers A. Efficacy and safety of triple versus dual combination blood pressure-lowering drug therapy: a systematic review and meta-analysis of randomized controlled trials. J Hypertens. 2019;37:1567\u201373.","journal-title":"J Hypertens"},{"key":"1190_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s40292-025-00720-1","volume":"32","author":"UG Adamu","year":"2025","unstructured":"Adamu UG, Mojela K, Adamu EU, Ojji D, Tsabedze N, et al. Efficacy and safety of low-dose triple single pill combination versus standard care in the management of hypertension in low- and middle-income countries: a systematic review and meta-analysis of three randomized controlled trials. High Blood Press Cardiovasc Prev. 2025;32:375\u201385. https:\/\/doi.org\/10.1007\/s40292-025-00720-1","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"1190_CR14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1161\/01.HYP.0000254479.66645.a3","volume":"49","author":"A Mahmud","year":"2007","unstructured":"Mahmud A, Feely J. Low-dose quadruple antihypertensive combination: more efficacious than individual agents-a preliminary report. Hypertension. 2007;49:272\u20135. https:\/\/doi.org\/10.1161\/01.HYP.0000254479.66645.a3","journal-title":"Hypertension"},{"key":"1190_CR15","doi-asserted-by":"publisher","first-page":"5735","DOI":"10.2147\/DDDT.S286586","volume":"14","author":"SJ Hong","year":"2020","unstructured":"Hong SJ, Sung KC, Lim SW, Kim SY, Kim W, Shin J, et al. Low-dose triple antihypertensive combination therapy in patients with hypertension: a randomized, double-blind, phase ii study. Drug Des Devel Ther. 2020;14:5735\u201346.","journal-title":"Drug Des Devel Ther"},{"key":"1190_CR16","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/jch.14570","volume":"24","author":"KC Sung","year":"2022","unstructured":"Sung KC, Sung JH, Cho EJ, Ahn JC, Han SH, Kim W, et al. Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: a randomized, double-blind, parallel, phase II trial. J Clin Hypertens. 2022;24:1298\u2013309. https:\/\/doi.org\/10.1111\/jch.14570","journal-title":"J Clin Hypertens"},{"key":"1190_CR17","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jama.2024.18080","volume":"332","author":"DB Ojji","year":"2024","unstructured":"Ojji DB, Salam A, Sani MU, Ogah OS, Schutte AE, Huffman MD, et al. Rodgers a. low-dose triple-pill vs standard-care protocols for hypertension treatment in nigeria: a randomized clinical trial. JAMA. 2024;332:1070\u20139. https:\/\/doi.org\/10.1001\/jama.2024.18080","journal-title":"JAMA"},{"key":"1190_CR18","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1001\/jamacardio.2022.0471","volume":"7","author":"SR Gnanenthiran","year":"2022","unstructured":"Gnanenthiran SR, Wang N, Di Tanna GL, Salam A, Webster R, de Silva HA, et al. TRIUMPH study group. association of low-dose triple combination therapy vs usual care with time at target blood pressure: a secondary analysis of the triumph randomized clinical trial. JAMA Cardiol. 2022;7:645\u201350. https:\/\/doi.org\/10.1001\/jamacardio.2022.0471","journal-title":"JAMA Cardiol"},{"key":"1190_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s40256-023-00590-9","volume":"23","author":"MC Kim","year":"2023","unstructured":"Kim MC, Ahn Y, Kim MH, et al. A randomized, multicenter, double-blind, placebo-controlled study to evaluate the efficacy and safety of a quadruple combination of amlodipine, losartan, rosuvastatin, and ezetimibe in patients with concomitant essential hypertension and dyslipidemia. Am J Cardiovasc Drugs. 2023;23:441\u201354. https:\/\/doi.org\/10.1007\/s40256-023-00590-9","journal-title":"Am J Cardiovasc Drugs"},{"key":"1190_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.clinthera.2025.08.003","volume":"48","author":"DH Kim","year":"2026","unstructured":"Kim DH, Lee SH, Han KA, Kim MH, Choi DJ, Grabowski M, et al. A phase III randomized controlled trial evaluating the efficacy and safety of azilsartan medoxomil and amlodipine combination therapy in patients with mild-to-moderate essential hypertension inadequately controlled on monotherapy. Clin Ther. 2026;48:159\u201369. https:\/\/doi.org\/10.1016\/j.clinthera.2025.08.003","journal-title":"Clin Ther"},{"key":"1190_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-03892-8","volume":"23","author":"X Zhao","year":"2025","unstructured":"Zhao X, Liu T, Yang Q, Yang G, Li X, Tang X, et al. Initial treatment with a single capsule containing half-dose quadruple therapy vs standard-dose dual therapy in hypertensive patients (QUADUAL): a randomized, blinded, crossover trial. BMC Med. 2025;23:56 https:\/\/doi.org\/10.1186\/s12916-025-03892-8","journal-title":"BMC Med"},{"key":"1190_CR22","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/s41440-024-01658-y","volume":"47","author":"MD Huffman","year":"2024","unstructured":"Huffman MD, Baldridge AS, Lazar D, Abbas H, Mejia J, Flowers FM, et al. Efficacy and safety of a four-drug, quarter-dose treatment for hypertension: the QUARTET USA randomized trial. Hypertens Res. 2024;47:1668\u201377. https:\/\/doi.org\/10.1038\/s41440-024-01658-y","journal-title":"Hypertens Res"},{"key":"1190_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jamacardio.2024.5124","volume":"10","author":"H Mapesi","year":"2025","unstructured":"Mapesi H, Rohacek M, Vanobberghen F, Gupta R, Wilson HI, Lukau B, et al. Treatment strategies to control blood pressure in people with hypertension in tanzania and lesotho: a randomized clinical trial. JAMA Cardiol. 2025;10:321\u201333. https:\/\/doi.org\/10.1001\/jamacardio.2024.5124","journal-title":"JAMA Cardiol"},{"key":"1190_CR24","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/S0140-6736(24)01744-6","volume":"404","author":"A Rodgers","year":"2024","unstructured":"Rodgers A, Salam A, Schutte AE, Cushman WC, de Silva HA, Di Tanna GL, et al. GMRx2 Investigators. Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial. Lancet. 2024;404:1536\u201346. https:\/\/doi.org\/10.1016\/S0140-6736(24)01744-6","journal-title":"Lancet"},{"key":"1190_CR25","doi-asserted-by":"publisher","first-page":"e41297","DOI":"10.1371\/journal.pone.0041297","volume":"7","author":"DS Wald","year":"2012","unstructured":"Wald DS, Morris JK, Wald NJ. Randomized Polypill crossover trial in people aged 50 and over. PLoS One. 2012;7:e41297 https:\/\/doi.org\/10.1371\/journal.pone.0041297","journal-title":"PLoS One"},{"key":"1190_CR26","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1016\/j.jacc.2024.08.025","volume":"84","author":"A Rodgers","year":"2024","unstructured":"Rodgers A, Salam A, Schutte AE, Cushman WC, de Silva HA, Di Tanna GL, et al. Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of Hypertension. J Am Coll Cardiol. 2024;84:2393\u2013403. https:\/\/doi.org\/10.1016\/j.jacc.2024.08.025","journal-title":"J Am Coll Cardiol"},{"key":"1190_CR27","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1001\/jama.2018.10359","volume":"320","author":"R Webster","year":"2018","unstructured":"Webster R, Salam A, de Silva HA, Selak V, Stepien S, Rajapakse S, et al. TRIUMPH study group. fixed low-dose triple combination antihypertensive medication vs usual care for blood pressure control in patients with mild to moderate hypertension in sri lanka: a randomized clinical trial. JAMA. 2018;320:566\u201379. https:\/\/doi.org\/10.1001\/jama.2018.10359","journal-title":"JAMA"},{"key":"1190_CR28","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(15)01225-8","journal-title":"Lancet"},{"key":"1190_CR29","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","volume":"326","author":"MR Law","year":"2003","unstructured":"Law MR, Wald NJ, Morris JK, Jordan RE, et al. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003;326:1427 https:\/\/doi.org\/10.1136\/bmj.326.7404.1427","journal-title":"BMJ"},{"key":"1190_CR30","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","volume":"122","author":"DS Wald","year":"2009","unstructured":"Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122:290\u2013300. https:\/\/doi.org\/10.1016\/j.amjmed.2008.09.038","journal-title":"Am J Med"},{"key":"1190_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/jhh.2017.5","volume":"31","author":"R D\u00fcsing","year":"2017","unstructured":"D\u00fcsing R, Waeber B, Destro M, Santos Maia C, Brunel P. Triple-combination therapy in the treatment of hypertension: a review of the evidence. J Hum Hypertens. 2017;31:501\u201310. https:\/\/doi.org\/10.1038\/jhh.2017.5","journal-title":"J Hum Hypertens"},{"key":"1190_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.109.139816","volume":"55","author":"AK Gupta","year":"2010","unstructured":"Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension. 2010;55:399\u2013407. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.139816","journal-title":"Hypertension"},{"key":"1190_CR33","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0140-6736(18)31814-2","volume":"392","author":"SP Kishore","year":"2018","unstructured":"Kishore SP, Salam A, Rodgers A, Jaffe MG, Frieden T. Fixed-dose combinations for hypertension. Lancet. 2018;392:819\u201320. https:\/\/doi.org\/10.1016\/S0140-6736(18)31814-2","journal-title":"Lancet"},{"key":"1190_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","volume":"134","author":"KT Mills","year":"2016","unstructured":"Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441\u201350. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018912","journal-title":"Circulation"},{"key":"1190_CR35","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.amjmed.2006.08.033","volume":"120","author":"S Bangalore","year":"2007","unstructured":"Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120:713\u20139. https:\/\/doi.org\/10.1016\/j.amjmed.2006.08.033","journal-title":"Am J Med"},{"key":"1190_CR36","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennision Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. Hypertension. 2018;71:1269\u2013324. https:\/\/doi.org\/10.1161\/HYP.0000000000000066","journal-title":"Hypertension"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01190-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01190-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01190-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:03:12Z","timestamp":1791486192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01190-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1190"],"URL":"https:\/\/doi.org\/10.1038\/s41371-026-01190-1","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}